Abstract
CABG surgery has been considered the optimal revascularization strategy for patients with diabetes mellitus who have lexft main and/or multivessel coronary artery disease. The results of a new analysis of data from the SYNTAX trial challenge this conventional wisdom and highlight additional coronary revascularization options to physicians and patients.
MeSH terms
-
Angioplasty, Balloon, Coronary / adverse effects
-
Angioplasty, Balloon, Coronary / instrumentation
-
Angioplasty, Balloon, Coronary / mortality
-
Coronary Artery Bypass* / adverse effects
-
Coronary Artery Bypass* / mortality
-
Coronary Artery Disease / complications
-
Coronary Artery Disease / mortality
-
Coronary Artery Disease / therapy*
-
Diabetes Mellitus, Type 2 / complications*
-
Diabetes Mellitus, Type 2 / mortality
-
Drug-Eluting Stents
-
Evidence-Based Medicine
-
Humans
-
Patient Selection
-
Randomized Controlled Trials as Topic
-
Risk Assessment
-
Risk Factors
-
Treatment Outcome